GlassScriptPhysician profile
Marina Byer
NPI 1700440625
$2,537.39
in general payments reported to CMS, 2019-2025
8 companies · $1,702 in 2025
The $1,702 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $340 · 2024: $496 · 2025: $1,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,626 · Travel and Lodging: $675 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,625.95 |
| Travel and Lodging | $674.63 |
| Education | $236.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $802.55 | 2023-2025 | Avvigo Guidance System, Sentinel, General - Therapies |
| Philips North America LLC | $674.63 | 2025 | Igt Devices Undivided |
| Medtronic, INC. | $412.60 | 2023-2025 | Onyx Frontier, Cobalt Dr Mri Surescan, Symplicity G3 |
| Abbott Laboratories | $382.48 | 2023-2025 | Ensite, Amplatzer Amulet |
| Pfizer INC. | $114.86 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $113.95 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $21.40 | 2025 | Wainua |
| E.R. Squibb & Sons, L.L.C. | $14.92 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Byer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.